These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10083474)

  • 21. Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospholipase A2 with LY329722.
    Ogata K; Jin MB; Taniguchi M; Suzuki T; Shimamura T; Kitagawa N; Magata S; Fukai M; Ishikawa H; Ono T; Furukawa H; Fujita M; Todo S
    Transplantation; 2001 Apr; 71(8):1040-6. PubMed ID: 11374398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective thromboxane A2 synthase inhibition by OKY-046 prevents cardiopulmonary dysfunction after ovine smoke inhalation injury.
    Westphal M; Noshima S; Isago T; Fujioka K; Maybauer MO; Maybauer DM; Traber LD; Flynn JT; Westphal-Varghese BB; Traber DL
    Anesthesiology; 2005 May; 102(5):954-61. PubMed ID: 15851882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy.
    Hora K; Oguchi H; Furukawa T; Hora K; Tokunaga S
    Nephron; 1990; 56(3):297-305. PubMed ID: 2077412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
    Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of arachidonic acid metabolites on leukocyte activation and skeletal muscle injury after ischemia and reperfusion.
    Cambria RA; Anderson RJ; Dikdan G; Lysz TW; Hobson RW
    J Vasc Surg; 1991 Oct; 14(4):549-56. PubMed ID: 1656104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effect of thromboxane A2 synthetase inhibitor on cold-stored rat liver.
    Suehiro T; Yanaga K; Itasaka H; Kishikawa K; Shirabe K; Sugimachi K
    Transplantation; 1994 Oct; 58(7):768-73. PubMed ID: 7940709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of dogs after 84% hepatectomy with emphasis on prostaglandin metabolites and the effect of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analog.
    Iwata M
    Surg Today; 1994; 24(12):1056-67. PubMed ID: 7780227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of intraportal infusion of adenosine on hepatic blood flow and injury after ischemia and reperfusion of canine liver.
    Sakata C; Tanaka H; Takemura S; Minamiyama Y; Nakamura A; Katsuragi K; Huang H; Kubo S; Hirohashi K; Kinoshita H
    Transplant Proc; 1999; 31(1-2):509-10. PubMed ID: 10083213
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of thromboxane A2 synthetase inhibitor on metabolism and contractility in ischemic reperfused rabbit heart.
    Kawabata H; Ryomoto T; Katori R
    Angiology; 1997 Aug; 48(8):689-97. PubMed ID: 9269138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model.
    Sunose Y; Takeyoshi I; Ohwada S; Tsutsumi H; Iwazaki S; Kawata K; Kawashima Y; Tomizawa N; Matsumoto K; Morishita Y
    J Am Coll Surg; 2001 Jan; 192(1):54-62. PubMed ID: 11192923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of intravenous infusion of OKY-1581 (sodium-(E)-3-[4-(3-pyridylmethyl)phenyl] -2-methylacrylate) on circulatory thromboxane A2 and prostacyclin levels in anaesthetized baboon.
    Roy AC; Adaikan PG; Karim SM
    Prostaglandins Med; 1981 Sep; 7(3):253-9. PubMed ID: 7029585
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of thromboxane synthetase inhibitor on cerebral circulation and metabolism during experimental cerebral ischemia in spontaneously hypertensive rats.
    Sadoshima S; Ooboshi H; Okada Y; Yao H; Ishitsuka T; Fujishima M
    Eur J Pharmacol; 1989 Oct; 169(1):75-83. PubMed ID: 2513212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of OKY-046, a selective thromboxane A2 synthetase inhibitor, on ventricular arrhythmias and prostaglandins during coronary artery ligation and reperfusion in anesthetized dogs.
    Ogura T; Watanabe I; Saito T; Saito S; Ozawa Y; Hatano M
    Jpn J Pharmacol; 1988 May; 47(1):95-8. PubMed ID: 3411822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte and platelet depletion protects the liver from damage induced by cholestasis and ischemia-reperfusion in the dog.
    Kuroda T; Shiohara E
    Scand J Gastroenterol; 1996 Feb; 31(2):182-90. PubMed ID: 8658042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thromboxane A2 mediates increased pulmonary microvascular permeability following limb ischemia.
    Klausner JM; Paterson IS; Goldman G; Kobzik L; Valeri CR; Shepro D; Hechtman HB
    Circ Res; 1989 Jun; 64(6):1178-89. PubMed ID: 2720919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intraportal infusion of adenosine on hepatic blood flow and injury after ischemia and reperfusion of canine liver.
    Sakata C; Tanaka H; Takemura S; Minamiyama Y; Nakamura A; Katsuragi K; Huang H; Kubo S; Hirohashi K; Kinoshita H
    Transplant Proc; 1999; 31(1-2):1027-8. PubMed ID: 10083457
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of ozagrel on locomotor and motor coordination after transient cerebral ischemia in experimental animal models.
    Ichikawa K; Tazawa S; Hamano S; Kojima M; Hiraku S
    Pharmacology; 1999 Nov; 59(5):257-65. PubMed ID: 10529658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of OKY-046 (thromboxane A2 synthetase inhibitor) on exercise-induced asthma.
    Hoshino M; Fukushima Y
    J Asthma; 1991; 28(1):19-29. PubMed ID: 1849133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of agiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver.
    Masuko H; Jin MB; Horiuchi H; Suzuki T; Taniguchi M; Shimamura T; Fukai M; Magata S; Ogata K; Ishikawa H; Fujita M; Nagashima K; Furukawa H; Todo S
    Transplantation; 2001 Apr; 71(8):1034-9. PubMed ID: 11374397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.